Latest filing published 07 Dec 2016 for Valeant Pharmaceuticals International, Inc., €339k.
Insider track record
No signal scores available.
Ari Kellen: trading record in brief
Filings by Ari Kellen span 2 companies, the busiest being Valeant Pharmaceuticals International, Inc. and Bausch Health Companies Inc. Over a trading history stretching from 20 January 2014 to 5 December 2016, the count stands at 5 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The newest entry dates from 7 December 2016: a share grant of €339k, in Valeant Pharmaceuticals International, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Ari Kellen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 19,932 shares@ US$18.00100.0% of flowCommon Stock, no par valueSEC:0001595698-16-000001:0
- 115,324 shares0Common Stock, no par valueSEC:0000885590-16-000110:0
- 3,317 sharesCommon Stock, no par valueSEC:0000885590-16-000086:0
- 4,855 shares0Common Stock, no par valueSEC:0000885590-15-000016:0
- 46,811 shares0Common Stock, no par valueSEC:0000885590-14-000010:0
5 of 5 declarations
